Tag: VIVA 2023
DRS combination of scaffold and antirestenotic drug will “really advance” treatment...
Principal investigators of the LIFE-BTK randomised controlled trial delve into the technological improvements underpinning the Esprit drug-eluting resorbable scaffold (DRS; Abbott) from its previous...
“First victory” in BTK space demonstrates lessons learned and paves the...
Lawrence Garcia (St Francis Hospital, New York, USA) speaks to Vascular News at VIVA 2023 (30 October–2 November, Las Vegas, USA) on lessons learned...
Optimal management of vascular wounds: Patient-specific decisions and multidisciplinary care are...
Vincent Rowe (University of California Los Angeles, Los Angeles, USA) speaks to Vascular News at VIVA 2023 (30 October–2 November, Las Vegas, USA) on...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid,...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
PROMISE II 12-month data show durable outcomes with the LimFlow system...
One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the...
InspireMD presents positive 30-day follow-up results from C-GUARDIANS clinical trial
InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for...
Contego announces low one-year stroke rates in PERFORMANCE II carotid stent...
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at VIVA 2023 (30 October–2 November, Las...
Getinge announces US commercial availability of iCast covered stent system for...
Getinge has announced commercial availability of the iCast covered stent system in the USA for the treatment of iliac arterial occlusive disease. In March...
